Ethoxyquin → Retinol

HRID 987358

Reaction equation

[CH3:1][C:2]1[CH2:7][CH2:6][CH2:5][C:4]([CH3:9])([CH3:8])[C:3]=1/[CH:10]=[CH:11]/[C:12](/[CH3:24])=[CH:13]/[CH:14]=[CH:15]/[C:16](/[CH3:23])=[CH:17]/[CH2:18][O:19]C(C)=O.CCOC1C=C2C(C)=CC(C)(C)NC2=CC=1>>[CH3:1][C:2]1[CH2:7][CH2:6][CH2:5][C:4]([CH3:8])([CH3:9])[C:3]=1/[CH:10]=[CH:11]/[C:12](/[CH3:24])=[CH:13]/[CH:14]=[CH:15]/[C:16](/[CH3:23])=[CH:17]/[CH2:18][OH:19]

Participants

Reactant 2

HCID 3293Ethoxyquin

HCID 638034Retinol, acetate

Product 1

HCID 445354Retinol

Procedure

mixture of vitamin A acetate, 2.8 million IU/G unstab. (80% by weight) (BASF AG) and ethoxyquin (20% by weight) (Raluquin, Raschig AG) were run in at 60° C. via a heated pump unit.

Workup

customwere run in at 60° C. via a heated pump unit

Sources & evidence

ORD record: ord-ef3ee44cf5574abaa8a8c7601bd53396
Source dataset: uspto-grants-2003_10
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US06632389B1

Linked notes

Loading…